Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-13-000968

Director bought 25,000 shares at $0.66 ($16,550)

  • Director acquired 1,503,570 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brauser Michael · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2013-05-10 Option exercise : show line 1 in the form +1,160,713 $0.21 $243,750 3,378,567 I
2013-05-13 Option exercise : show line 2 in the form +342,857 $0.21 $72,000 3,721,424 I
2013-05-13 Purchase : show line 3 in the form +25,000 $0.66 $16,550 4,519,926 D
Open-market purchases · 25,000 sh · avg $0.66 · $16,550

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-05-10 Option exercise : show line 4 in the form Warrants to Purchase Common Stock −1,160,713 $0.21 2013-05-20 1,160,713 342,857 I
2013-05-13 Other disposition : show line 5 in the form Warrants to Purchase Common Stock −342,857 $0.21 2013-05-20 342,857 0 I
2013-05-13 Other acquisition : show line 6 in the form Warrants to Purchase Common Stock +342,857 $0.21 2013-05-20 342,857 342,857 I
2013-05-13 Option exercise : show line 7 in the form Warrants to Purchase Common Stock −342,857 $0.21 2013-05-20 342,857 0 I
Loading xslF345X03/form4-05142013_090530.xml…